rs562025438

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBP6_Very_Strong

The ENST00000490077.5(TNXB):​n.2601G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 2 hom., cov: 23)
Exomes 𝑓: 0.024 ( 23 hom. )
Failed GnomAD Quality Control

Consequence

TNXB
ENST00000490077.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.189

Publications

0 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CYP21A2 Gene-Disease associations (from GenCC):
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 6-32041310-C-T is Benign according to our data. Variant chr6-32041310-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 261093.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.*39G>A 3_prime_UTR_variant Exon 44 of 44 ENST00000644971.2 NP_001352205.1
CYP21A2NM_000500.9 linkc.*176C>T 3_prime_UTR_variant Exon 10 of 10 ENST00000644719.2 NP_000491.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.*39G>A 3_prime_UTR_variant Exon 44 of 44 NM_001365276.2 ENSP00000496448.1
CYP21A2ENST00000644719.2 linkc.*176C>T 3_prime_UTR_variant Exon 10 of 10 NM_000500.9 ENSP00000496625.1

Frequencies

GnomAD3 genomes
AF:
0.0178
AC:
2626
AN:
147624
Hom.:
2
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00352
Gnomad AMI
AF:
0.00463
Gnomad AMR
AF:
0.0212
Gnomad ASJ
AF:
0.00976
Gnomad EAS
AF:
0.00362
Gnomad SAS
AF:
0.0203
Gnomad FIN
AF:
0.0322
Gnomad MID
AF:
0.0128
Gnomad NFE
AF:
0.0247
Gnomad OTH
AF:
0.0245
GnomAD2 exomes
AF:
0.0207
AC:
2995
AN:
144950
AF XY:
0.0222
show subpopulations
Gnomad AFR exome
AF:
0.00293
Gnomad AMR exome
AF:
0.0156
Gnomad ASJ exome
AF:
0.00846
Gnomad EAS exome
AF:
0.00421
Gnomad FIN exome
AF:
0.0341
Gnomad NFE exome
AF:
0.0251
Gnomad OTH exome
AF:
0.0185
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0240
AC:
15183
AN:
633796
Hom.:
23
Cov.:
8
AF XY:
0.0242
AC XY:
8160
AN XY:
336810
show subpopulations
African (AFR)
AF:
0.00301
AC:
52
AN:
17274
American (AMR)
AF:
0.0153
AC:
531
AN:
34736
Ashkenazi Jewish (ASJ)
AF:
0.00806
AC:
165
AN:
20484
East Asian (EAS)
AF:
0.00524
AC:
170
AN:
32460
South Asian (SAS)
AF:
0.0252
AC:
1624
AN:
64436
European-Finnish (FIN)
AF:
0.0346
AC:
1625
AN:
46980
Middle Eastern (MID)
AF:
0.0144
AC:
39
AN:
2714
European-Non Finnish (NFE)
AF:
0.0269
AC:
10250
AN:
381644
Other (OTH)
AF:
0.0220
AC:
727
AN:
33068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.419
Heterozygous variant carriers
0
713
1426
2140
2853
3566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0178
AC:
2625
AN:
147742
Hom.:
2
Cov.:
23
AF XY:
0.0179
AC XY:
1287
AN XY:
71956
show subpopulations
African (AFR)
AF:
0.00351
AC:
141
AN:
40170
American (AMR)
AF:
0.0211
AC:
316
AN:
14944
Ashkenazi Jewish (ASJ)
AF:
0.00976
AC:
33
AN:
3382
East Asian (EAS)
AF:
0.00363
AC:
18
AN:
4962
South Asian (SAS)
AF:
0.0201
AC:
89
AN:
4422
European-Finnish (FIN)
AF:
0.0322
AC:
329
AN:
10228
Middle Eastern (MID)
AF:
0.0138
AC:
4
AN:
290
European-Non Finnish (NFE)
AF:
0.0247
AC:
1642
AN:
66462
Other (OTH)
AF:
0.0243
AC:
49
AN:
2018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
110
220
330
440
550
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0187
Hom.:
2

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 10, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
11
DANN
Benign
0.88
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs562025438; hg19: chr6-32009087; API